Mitsutaka Nakamura

Pharmacological Profile of Lurasidone, a Novel Antipsychotic Agent with Potent 5-Hydroxytryptamine 7 (5-HT7) and 5-HT1A Receptor Activity

Tadashi Ishibashi, Tomoko Horisawa, Kumiko Tokuda et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 422 citations

Lurasidone in the Treatment of Acute Schizophrenia

Mitsutaka Nakamura, Masaaki Ogasa, John Guarino et al. · The Journal of Clinical Psychiatry · 2009 · 192 citations

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

Masaaki Ogasa, Tatsuya Kimura, Mitsutaka Nakamura et al. · Psychopharmacology · 2012 · 116 citations · Full text

Pharmacological properties of SM-3997: A new anxioselective anxiolytic candidate.

Hiroshi Shimizu, Akira Hirose, Tohru Tatsuno et al. · The Japanese Journal of Pharmacology · 1987 · 86 citations · Full text

Molecular Pharmacology, Dopamine Antagonistic Action, Pharmacological Study +13

Pharmacological Actions of SM-9018, a New Neuroleptic Drug with Both Potent 5-Hydroxytryptamine2 and Dopamine2 Antagonistic Actions

Akira Hirose, Terufumi Kato, Yukihiro Ohno et al. · The Japanese Journal of Pharmacology · 1990 · 60 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +17